Among all predicted lncRNAs, nine lncRNAs (SNHG1, SNHG12, LINC00511, HCG18, FGD5-AS1, CERS6-AS1, NUTM2A-AS1, SNHG16, and ASB16-AS1) were significantly upregulated in hepatocellular carcinoma and their upregulation linked to poor prognosis of patients with hepatocellular carcinoma. The gene discussed is NUTM2A; the disease is hepatocellular carcinoma.